Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 389Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 69ANTARES PHARMA INC

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

TESTOSTERONE ENANTHATE

US Patent Number : 9950125

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209863

Patent Use Code : U-2418

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-09-04

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

TESTOSTERONE ENANTHATE

US Patent Number : 9950125

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209863

Patent Use Code : U-2418

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-09-04

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

TESTOSTERONE ENANTHATE

US Patent Number : 10912782

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209863

Patent Use Code : U-2418

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-02-19

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

TESTOSTERONE ENANTHATE

US Patent Number : 10912782

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209863

Patent Use Code : U-2418

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-02-19

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

TESTOSTERONE ENANTHATE

US Patent Number : 10912782

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209863

Patent Use Code : U-2418

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-02-19

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

TESTOSTERONE ENANTHATE

US Patent Number : 11844804

Drug Substance Claim :

Drug Product Claim :

Application Number : 209863

Patent Use Code : U-2418

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-06-04

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

TESTOSTERONE ENANTHATE

US Patent Number : 11844804

Drug Substance Claim :

Drug Product Claim :

Application Number : 209863

Patent Use Code : U-2418

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-06-04

blank

08

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

TESTOSTERONE ENANTHATE

US Patent Number : 11844804

Drug Substance Claim :

Drug Product Claim :

Application Number : 209863

Patent Use Code : U-2418

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-06-04

blank

09

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

TESTOSTERONE ENANTHATE

US Patent Number : 9950125

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209863

Patent Use Code : U-2418

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-09-04

blank

10

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

TESTOSTERONE ENANTHATE

US Patent Number : 10821072

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209863

Patent Use Code : U-2418

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-06-04

blank